Lord, Abbett & Co. LLC Iveric Bio, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 07, 2024
BUY
$18.67 - $24.56 $119,058 - $156,619
6,377 Added 3.9%
169,710 $4.13 Million
Q1 2023

May 12, 2023
BUY
$18.67 - $24.56 $119,058 - $156,619
6,377 Added 3.9%
169,710 $4.13 Million
Q4 2022

Oct 07, 2024
BUY
$17.24 - $23.95 $2.82 Million - $3.91 Million
163,333 New
163,333 $3.5 Million
Q4 2022

Feb 10, 2023
BUY
$17.24 - $23.95 $2.82 Million - $3.91 Million
163,333 New
163,333 $3.5 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email